medroxyprogesterone has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clavel, B | 1 |
| Laros, RK | 1 |
1 review(s) available for medroxyprogesterone and Leukemia
| Article | Year |
|---|---|
[Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Hormones; Humans; Immunity, Cellular; Immunotherapy; Kidney Neoplasms; Leukemia; Lung Neoplasms; Lymphoma; Male; Medroxyprogesterone; Methods; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Testosterone; Thyroid Neoplasms; Viral Interference | 1974 |
1 other study(ies) available for medroxyprogesterone and Leukemia
| Article | Year |
|---|---|
Therapeutic amenorrhea in hematologic disorders.
Topics: Adult; Amenorrhea; Anemia, Aplastic; Blood Cell Count; Blood Platelets; Estrogens; Female; Hematologic Diseases; Humans; Leukemia; Medroxyprogesterone; Menorrhagia; Mestranol; Norethynodrel; Progesterone; Purpura, Thrombocytopenic | 1971 |